Active Pharmaceutical Ingredients
What is Boswellia Serrata Extract?
Boswellia serrata is a tree native to India, the Middle East, and Northern Africa. Its resin, rich in triterpenic acids like , boswellic acids, it has been used for centuries in Ayurvedic medicine to treat inflammatory conditions. Modern extracts are derived from the tree’s oleoresin and are marketed for their anti-inflammatory, analgesic, and potential neuroprotective properties.it is very popular in healthcare food market.
COA
| ITEM | SPECIFICATION | RESULT | TEST METHOD |
|---|---|---|---|
| Physical Description | |||
| Appearance | Milky white powder | Conforms | Visual |
| Odor | Characteristic odor | Conforms | Organoleptic |
| Particle Size | 100%Through 80 Mesh | Conforms | CP2020 |
| Chemical Tests | |||
| Boswellia Acid | ≥65% | Conforms | Titration |
| Moisture | ≤5.0% | 4.10% | CP2020 |
| Ash | ≤5.0% | 3.80% | CP2020 |
| Total Heavy Metals | <10 ppm | Conforms | CP2020 |
| Microbiology Control | |||
| Aerobic Bacterial Count | ≤1,000 CFU/g | Conforms | GB4789.2 |
| Yeast | ≤100 CFU/g | Conforms | GB4789.15 |
| Mold | ≤100 CFU/g | Conforms | GB4789.15 |
| Escherichia Coli | ≤3.0MPN/g | Conforms | GB4789.38 |
| Salmonella | Not Detected | Conforms | GB4789.4 |
| Staphylococcus Aureus | Not Detected | Conforms | GB4789.10 |
| Conclusion | Conforms to Specification | - | - |
Who Should Not Take Boswellia?
Pregnant or Breastfeeding Women: it is belong to sensitive group. Limited safety data exist; avoid use to prevent potential risks to the fetus or infant.
Individuals on Anticoagulants/Antiplatelets: For boswellia may enhance bleeding risk due to its anti-inflammatory effects, it can interfere with blood clotting.
Those with Gastrointestinal Disorders: for high doses may cause stomach irritation, nausea, or diarrhea, particularly in people with ulcers or inflammatory bowel disease.
Allergy-Prone Individuals: Rare allergic reactions like skin rashes, itching, it have been reported; discontinue use if symptoms occur.
Pre-Surgery Patients: Must stop use at least 2 weeks before surgery to minimize bleeding risks.
Individuals on Anticoagulants/Antiplatelets: For boswellia may enhance bleeding risk due to its anti-inflammatory effects, it can interfere with blood clotting.
Those with Gastrointestinal Disorders: for high doses may cause stomach irritation, nausea, or diarrhea, particularly in people with ulcers or inflammatory bowel disease.
Allergy-Prone Individuals: Rare allergic reactions like skin rashes, itching, it have been reported; discontinue use if symptoms occur.
Pre-Surgery Patients: Must stop use at least 2 weeks before surgery to minimize bleeding risks.
What does Boswellia do to the brain?
Reduces Brain Edema: Studies indicate boswellia serrata extract may alleviate swelling (edema) caused by radiation therapy in brain tumor patients, and it improve symptoms like headaches and neurological deficits.
Potential Cognitive Benefits: A 2022 pilot trial suggested Boswellia extract improved memory and attention in individuals with traumatic brain injury, though larger studies are needed.
Anti-Inflammatory Action: By inhibiting pro-inflammatory enzymes (e.g., 5-lipoxygenase), Boswellia may protect brain tissue from inflammation-related damage.
where to buy Boswellia Serrata Extract?
Buy Boswellia Serrata Extract - Contact SoST Biotech Factory for:
✓ Bulk discounts (MOQ 25kg)
✓ FREE 20g samples with COA
✓ OEM services/Specification Customization
Email:ericyang@xasost.com
Packing & Shipping
What We Can Do?
Product Data Sheets
| Analysis | Description | Test Method |
| Appearance | Off-white PowderPowder | Visual |
| Odor | Characteristic | Nasil |
| Identification | Conform with reference sample | HPLC |
| Mesh Size | 100% pass 80 mesh | CP2020 |
| Moisture Content | ≤2.0% | GB5009.3 |
| Ash Content | ≤2.0% | GB5009.4 |
| Heavy Metals | ≤ 10 ppm | CP2020 |
| Arsenic (As) | ≤ 1.0 ppm | CP2020 |
| Lead (Pb) | ≤ 3.0 ppm | CP2020 |
| Cadmium (Cd) | ≤ 1.0 ppm | CP2020 |
| Mercury (Hg) | ≤ 1.0 ppm | CP2020 |
| Total Plate Count | ≤ 1,000 cfu/g | CP2020 |
| Yeast and Mold | ≤ 100 cfu/g | CP2020 |
| Escherichia Coli | Absent | CP2020 |
| Salmonella/25g | Absent | CP2020 |
| Assay(Dihydromyricetin) | ≥ 98% | HPLC |